Article thumbnail

Bacteriophage Administration Reduces the Concentration of Listeria monocytogenes in the Gastrointestinal Tract and Its Translocation to Spleen and Liver in Experimentally Infected Mice

By Volker Mai, Maria Ukhanova, Lee Visone, Tamar Abuladze and Alexander Sulakvelidze


To investigate the efficacy of phage supplementation in reducing pathogen numbers, mice were treated via oral gavage with a Listeria monocytogenes phage preparation (designated ListShield) before being orally infected with L. monocytogenes. The concentrations of L. monocytogenes in the liver, spleen, and intestines were significantly lower (P < .05) in the phage-treated than in the control mice. Phage and antibiotic treatments were similarly effective in reducing the levels of L. monocytogenes in the internal organs of the infected mice. However, the significant weight loss detected in the control and antibiotic-treated groups was not observed in the infected, ListShield-treated mice. Long-term (90 days), biweekly treatment of uninfected mice with ListShield did not elicit detectable changes in the microbiota of their large intestines or deleterious changes in their health. Our data support the potential feasibility of using bacteriophages to control proliferation of L. monocytogenes in mice without affecting commensal microbiota composition

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1997). A r a u j o ,A .P u i g ,J .L a s o b r a s ,F .L u c e n a ,a n dJ .J o f r e , “Phages of enteric bacteria in fresh water with different levels of faecal pollution,”
  2. (1993). A simple, rapid and sensitive presence/absence detection test for bacteriophage in drinking water,”
  3. (2003). Bacteriophage isolation from human saliva,”
  4. (2001). Bacteriophage therapy for bacterial infections: rekindling a memory from the pre-antibiotics era,”
  5. (2005). Bacteriophage therapy in humans,”
  6. (2001). Bacteriophage therapy,”
  7. (1997). Bacteriophages of enteric bacteria in drinking water, comparison of their distribution in two countries,”
  8. (1971). Characterization of two psychrophilic pseudomonas bacteriophages isolated from groundbeef,”AppliedMicrobiology,vol.22,no.3,pp.463–468,
  9. Current and potential uses of probiotics,”
  10. (1998). E.G.Zoetendal,A.D.L.Akkermans,andW.M.DeVos,“Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria,”
  11. (1959). Enumeration of Bacteriophage Particles, Bacteriophages,
  12. (1999). Evaluation and optimization of DNA extraction and purifi-cation procedures for soil and sediment samples,”
  13. (2003). Gut flora in health and disease,”
  14. (1989). High abundance of viruses found in aquatic environments,”
  15. (2005). Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy,” Antimicrobial Agents and Chemotherapy,v o l .4 9 ,n o .7 ,p p .
  16. (1971). Isolation of psychrophilic bacteriophage-host systems from refrigerated food products,”
  17. (1998). l i s k y ,K .I c z k o w s k i ,A .R a p o p o r t ,a n dN .T r o i t s k y ,“ B a c t e -riophages show promise as antimicrobial agents,”
  18. (2003). Metagenomic analyses of an uncultured viral community from human feces,”
  19. (1986). Methodology for enumeration of coliphages in foods,”
  20. (1959). Methods of Study Bacterial Viruses, Bacteriophages, Interscience Publishers,
  21. (2002). o n ,A .d eM o r e n od eL e B l a n c ,J .V a l d e z ,a n dM . Rachid, “Role of yoghurt in the prevention of colon cancer,”
  22. (1999). Occurrence and levels of phages proposed as surrogate indicators of enteric viruses in different types of sludges,”
  23. (2005). Phage ecology,” in Bacteriophages: Biology
  24. (2002). Phage genomics: small is beautiful,”
  25. (2005). Phage therapy in animals and agribusiness,”
  26. phages against Escherichia coli diarrhea: potential and problems,”
  27. (1986). Practical direct plaque assay for coliphages in 100-ml samples of drinking water,”
  28. (2004). Probiotics, prebiotics and child health: where are we going?”
  29. (2005). Probiotics: an emerging therapy,”
  30. (1984). Recovery of coliphages from chicken, pork sausage and delicatessen meats,” J o u r n a lo fF o o dP r o t e c t i o n ,
  31. (2004). T a r a n t o ,G .P e r d i g´
  32. (2004). The causes of intestinal dysbiosis: a review,”
  33. (2003). The prospect for bacteriophage therapy in